Kymera Therapeutics Inc (NAS:KYMR)
$ 50.94 1.09 (2.19%) Market Cap: 3.30 Bil Enterprise Value: 2.84 Bil PE Ratio: 0 PB Ratio: 3.69 GF Score: 50/100

Kymera Therapeutics Inc at Bank of America Global Healthcare Conference Transcript

May 10, 2023 / 08:40PM GMT
Release Date Price: $28.44 (+2.56%)
Geoffrey Christopher Meacham
BofA Securities, Research Division - Research Analyst

Okay. Perfect. Welcome to the Second Day of the BofA Healthcare Conference. I'm Geoff Meacham. I'm the senior biopharma analyst here. We're thrilled to have Kymera with us. And on stage with me is Nello Mainolfi, who is the Founder, President and CEO. I got the name right, right?

Nello Mainolfi
Kymera Therapeutics, Inc. - Co-Founder, President, CEO & Director

Perfect, Geoff. Love it.

Questions & Answers

Geoffrey Christopher Meacham
BofA Securities, Research Division - Research Analyst

So maybe to kick it off, Nello give us just a high-level view here and just talk through kind of targeted protein degradation and kind of where you guys sit?

Nello Mainolfi
Kymera Therapeutics, Inc. - Co-Founder, President, CEO & Director

Excellent. So first, Geoff, thank you for inviting us. This is a great conference. We love being here, and you guys do a really great job.

So

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot